The trial did not reach statistical significance for the primary endpoint of improvement in progression-free survival (PFS) A numeric improvement...
The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness DayThis social media–driven initiative...
Live virtual fireside chat — investors, advisors, and life sciences analysts invited to attendFeaturing Dermatologist Mary Spellman, M.D., with Phio...
Completion of Lead Clinical Candidate PH-762 Dose Escalation Trial for Treatment of Skin Cancer with Favorable Safety and Pathology DataKey...
Halo Care Skin Tag Remover Sanguinaria Canadensis and Zincum Muriaticum Formula Explained: 2026 Pricing, Refund, and Dermatologist GuidanceNew York, NY,...
Reports first quarter revenue of $0.4 billion, with approximately 80% of revenue from international marketsReports first quarter GAAP net loss...
Following a recent FSDPA speaking engagement, the Tampa-area dermatologist continues a spring schedule of community health initiatives and dermatology education...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales (recorded by Sanofi) increased...
Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancersHOUSTON, April 28, 2026 (GLOBE...
WOBURN, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the...
Builds Support for Accelerated Access to SkinJect® for Gorlin Syndrome patients with a Rare Autosomal Dominant DiseasePHILADELPHIA, April 27, 2026...
MESA, AZ / ACCESS Newswire / April 23, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a strategic...
HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing...
Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier...
TNX-1700 (TFF2-albumin fusion protein) reversed aging-associated gastric inflammation and significantly attenuated tumor progression in aged gastric microenvironment in preclinical models...
Moderna to host an investor event via webcast on Monday, June 1 at 6:15 PM CDT CAMBRIDGE, MA / ACCESS...
Moderna to host an investor event via webcast on Monday, June 1 at 6:15 PM CDT CAMBRIDGE, MA / ACCESS...
Moderna to host an investor event via webcast on Monday, June 1 at 6:15 PM CDT CAMBRIDGE, MA / ACCESS...
Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line modelsImmune cells...
Confirmed responses deepened with an average maximum tumor reduction from baseline of 89% and median time on treatment increased to...